Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerance and acceptability of rasagiline in early-stage Parkinson's disease
2007-007397-28Phase 4Active
- Sponsor
- Qualissima
- Start
- Aug 2008
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rasagiline in Parkinson's disease (PD) (2 arms), sponsored by Qualissima. Primary endpoint: Significant adverse events incidence. Started Aug 2008; status: active.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2007-007397-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007397-28.